| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cell Biology |


* Renal Immunobiology and Medical Research Council Centre for Immune Regulation and
CR-UK Institute for Cancer Studies, Birmingham University, Birmingham, United Kingdom
Address correspondence to: Dr. Michael J.O. Wakelam, CR-UK Institute for Cancer Studies, Birmingham University, Birmingham B15 2TT, UK. Phone: +44-121-4143293; Fax: +44-121-4144486; E-mail: m.j.o.wakelam{at}bham.ac.uk
Received for publication September 7, 2006. Accepted for publication January 31, 2007.
Patients with certain forms of systematic vasculitis, such as Wegener's granulomatosis, have circulating antineutrophil cytoplasmic antibodies (ANCA). These inappropriately stimulate circulating neutrophils adhere to and thereby obstruct small vessels. This, together with ANCA-induced degranulation and an oxidative burst, leads to local tissue damage. The signaling pathways that are activated by ANCA IgG are distinct from those that are involved in normal neutrophil activation. This study shows that diacylglycerol kinase is selectively activated by ANCA and that the generated phosphatidic acid is responsible for promoting neutrophil adhesion, in part through integrin activation. The data presented point to diacylglycerol kinase
as a novel but selective target for the development of drugs to treat this potentially fatal disorder.
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673